Last reviewed · How we verify
NCT04503109: nPower™-US
Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System
NA trial testing Nalu Neurostimulation System in Pain, Chronic in 110 participants. Completed in 13 September 2022.
13 September 2022
Quick facts
| Lead sponsor | Nalu Medical, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 16 July 2020 |
| Primary completion | 13 September 2022 |
| Estimated completion | 13 September 2022 |
| Sites | 8 locations across United States |
Drugs / interventions tested
- Nalu Neurostimulation System
Conditions studied
- Pain, Chronic — all drugs for Pain, Chronic →
- Pain, Intractable — all drugs for Pain, Intractable →
- Pain, Back — all drugs for Pain, Back →
Sponsor
Nalu Medical, Inc. — full company profile →
Who can join
Adults 21 to 80, any sex, with Pain, Chronic or Pain, Intractable. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Nalu Neurostimulation System is capable of delivering multiple therapy options to address patient needs. The study will confirm the efficacy, safety, comfort and compliance with the Nalu Neurostimulation System in adult subjects with chronic pain in the legs and back. Patients who have been diagnosed with failed back surgery syndrome (FBSS) and meet other study eligibility criteria will be enrolled in the study to receive the Nalu Neurostimulation System.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04503109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain, Chronic
Currently open trials in the same condition.
- NCT06800209 — Pain Reprocessing Therapy in Post-Operative Knee Pain · Phase 2 · recruiting
- NCT06512727 — The PROACTIVE Study for Black Elders · NA · recruiting
- NCT06837857 — Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain · Phase 2 · recruiting
- NCT06541184 — Ziconotide for Non-cancer Pain by Intrathecal Administration · recruiting
- NCT06592053 — Affecting Factors for Chronic Pain After Mastectomy · recruiting
Other Nalu Medical, Inc. trials
Trials by the same sponsor.
- NCT05870124 — Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2) · NA · active not recruiting
- NCT05287373 — Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04503109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nalu Medical, Inc.
- Last refreshed: 15 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04503109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing